Key aspects of choosing antipyretic therapy in pediatric practice

Introduction. Currently, nonsteroidal anti-inflammatory drugs with anti-inflammatory, analgesic, and antipyretic effects are widely used in clinical practice.

Aim. To obtain additional data on the efficacy and safety of paracetamol and ibuprofen in children with acute respiratory infections accompanied by fever.

Materials and methods. A single-center (observational) study was conducted involving 32 children (5.2 ± 1.8 years) with fever due to acute respiratory disease. At temperatures above 38.5 °C, an antipyretic in the form of forte was prescribed in an age-specific dosage according to the instructions for a course of 3 days. Patients of the first group (n = 16) were prescribed paracetamol against the background of standard therapy for the underlying disease according to the nosology, children of the second group – ibuprofen forte in syrup without fragrances, dyes and flavor additives. The average daily temperature, frequency and duration of taking the study drugs, the development of adverse reactions, a score of satisfaction with parents/legal representatives of the use of antipyretics and quality of life were taken into account.

Results. The result of therapy was clinical improvement: normalization of temperature (below 37.2 °C) over time with analysis of average daily values after 1, 4 hours, 1, 2, 3 days. The patients of both groups did not need to take antipyretics after 10 hours in 47.1% of cases, after 18 hours – in 53.8%. Noted the absence of adverse drug and allergic reactions and drug rejection by children, which confirms their safety. The average satisfaction rating of parents/legal representatives was 4.87 ± 0.23 (96.2% rated the effects of the studied drugs as “satisfied” and “completely satisfied”). The quality of life improved significantly with normalization of temperature by the end of the 3 days (1.92 ± 0.07).

Discussion. The drugs ibuprofen and paracetamol are safe for use in pediatric practice if the dosage rules are followed and are approved for use by the World Health Organization, the FDA and other expert organizations. In addition, the emergence of new forms of release of these drugs is most important in pediatrics.

Conclusions. The study conducted allows us to state the effectiveness of paracetamol and ibuprofen in the form of tablets and forte without fragrances, dyes and flavors, when taken in the correct dosage, which resulted in the relief of fever against the background of acute respiratory infections and an improvement in the quality of life.

1. Boivin JM, Weber F, Fay R, Monin P. Management of paediatric fever: is parents’ skill appropriate? Arch Pediatr. 2007;14:322–329. https://doi.org/10.1016/j.arcped.2006.12.018.

2. Porth CM, Kunert MP. Alteracoes na regulacao da temperatura. In: Porth CM, Kunert MP. Fisiopatologia. 6a ed. Rio de Janeiro: Guanabara Koogan; 2004, pp. 190–201.

3. Ushkalova EA. Selection of the optimal antipyretic agent in pediatric practice. Lechaschi Vrach. 2012;(8):66—69. (In Russ.) Available at: https://www.lvrach.ru/2012/08/15435506.

4. Studenikin VM, Akoev YuS. Antipyretics/analgesics in modern pediatrics: allopathy and homeopathy. Lechaschi Vrach. 2016;(6):7–10 (In Russ.) Available at: https://www.lvrach.ru/2016/06/15436486.

5. Studenikin VM, Akoev YuS. Tension headache in children, adolescents and adults: the role of NSAIDs. Lechaschi Vrach. 2015;(11):55–58. (In Russ.) Available at: https://www.lvrach.ru/2015/11/15436340.

6. Paracétamol ou ibuprofène chez les jeunes enfants. Continuer à préférer le paracétamol. Rev Prescrire. 2022;(42):211–212.

7. Korovina NA, Zakharova IN, Zaplatnikov AL. Acute fever in children. RMJ. 2005;(17):1165–1170. (In Russ.) Available at: https://www.rmj.ru/articles/obshchie-stati/Ostraya_lihoradka_u_detey/?utm_source=google.com&utm_medium=organic&utm_campaign=google.com&utm_referrer=google.com.

8. Timchenko VN, Pavlova EB. Modern approaches to the treatment of fever in children with infectious pathology. RMJ. 2008;(3):113–117. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Sovremennye_podhody_k_terapii_lihoradki_u_detey_s_infekcionnoy_patologiey.

9. Cremer OL, Kalkman CJ. Cerebral pathophysiology and clinical neurology of hyperthermia in humans. Prog Brain Res. 2007;162:153–169. https://doi.org/10.1016/S0079-6123(06)62009-8.

10. Niven DJ, Leger C, Kubes P, Stelfox HT, Laupland KB. Assessment of the safety and feasibility of administering anti-pyretic therapy in critically ill adults: study protocol of a randomized trial. BMC Res Notes. 2012;5:147. Available at: https://www.clinicalkey.jp/#!/content/journal/1-s2.0-S0883944112002997.

11. Kolosova NG, Dronov IA, Sboeva SG. Symptomatic therapy for acute respiratory infections in children. Clinical Practice in Pediatrics. 2019;14(6):72–77. (In Russ.) https://doi.org/10.20953/1817-7646-2019-6-72-77.

12. Geppe NA. The place of ibuprofen in antipyretic therapy of children with allergic conditions. Сonsilium Medicum. 2003;(6). (In Russ.)

13. Лобзин ЮВ, Усков АН, Горелов АВ, Усенко ДВ, Плоскирева АА, Бабаченко ИВ и др. Острые респираторные вирусные инфекции (ОРВИ) у детей: клинические рекомендации. 2022. Режим доступа: https://ipoeasid.ru/wp-content/uploads/2022/05/ORVI-deti-EAOIB-NASIB.pdf.

14. Zaplatnikov AL. Rational use of antipyretic drugs for acute respiratory viral infections in children. RMJ. 2009;(19):1223–1236. (In Russ.) Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Racionalynoe_primenenie_gharoponighayuschihlekarstvennyh_sredstv_pri_ORVI_u_detey.

15. Ketova GG. Features of the use of antipyretic drugs in children. RMJ. 2008;(18):1170–1172. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Osobennosti_ispolyzovaniya_gharoponighauschih_preparatov_u_detey.

16. Zakharova IN, Berezhnaya IV, Sugyan NG, Svintsitskaya VI, Novikov DV, Fedorov PV et al. Antipyretic drugs: benefits and adverse effects. Meditsinskiy Sovet. 2022;16(12):136–144. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-12-136-144.

17. Lokshina EE, Zaitseva OV, Zaitseva SV. Fever in children: a review of national and international studies and clinical guidelines. Russian Bulletin of Perinatology and Pediatrics. 2020;65(3):153–159. (In Russ.) https://doi.org/10.21508/1027-4065-2020-65-3-153-159.

18. Tatochenko VK. Rational use of antipyretic drugs in children. RMJ. 2000;(1):40. (In Russ.) Available at: https://www.rmj.ru/articles/obshchiestati/Racionalynoe_primenenie_gharoponighayuschih_sredstv_u_detey.

19. Таточенко ВК, Бакрадзе МД. Педиатру на каждый день – 2022. Лихорадки. М.: ФГАУ «НМИЦ здоровья детей» Минздрава России; 2022. C. 33–38. Режим доступа: https://nczd.ru/2023-07-28.

20. Zaitseva OV. Fever and pain. What is behind the symptoms? Paediatrician Practice. 2022;(4):72–73. (In Russ.) Available at: https://medi.ru/pp/2022/05/27614/

21. Geppe NA, Kolosova NG, Malakhov AB, Velikoretskaya MD, Kozhevnikova TN, Pivikina TM et al. Treatment of fever in children with acute respiratory tract infections. Doctor.Ru. 2021;20(10):6–11. (In Russ.) https://doi.org/10.31550/1727-2378-2021-20-10-6-11.

22. Barbagallo M, Sacerdote P. Ibuprofen in the treatment of children’s inflammatory pain: a clinical and pharmacological overview. Minerva Pediatr. 2019;71(1):82–99. https://doi.org/10.23736/S00264946.18.05453-1.

23. Luo S, Ran M, Luo Q, Shu M, Guo Q, Zhu Y et al. Alternating acetaminophen and ibuprofen versus monotherapies in improvements of distress and reducing refractory fever in febrile children: a randomized controlled trial. Paediatr Drugs. 2017;19(5):479–486. https://doi.org/10.1007/s40272-017-0237-1.

24. Brodie BB, Axelrod JJ. The fate of acetanilide in man. J Pharmacol Exp Ther. 1948;94(1):29–38. Available at: https://pubmed.ncbi.nlm.nih.gov/18885611.

25. Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Evid Based Child Health. 2014;9(3):675–729. https://doi.org/10.1002/ebch.1978.

26. Bushra R, Aslam N. An overview of clinical pharmacology of Ibuprofen. Oman Med J. 2010;25(3):155–1661. https://doi.org/10.5001/omj.2010.49.

27. Chalmers TM. Clinical experience with Ibuprofen in the treatment of rheumatoid arthritis. Ann Rheum Dis. 1969;28(5):513–517. https://doi.org/10.1136/ard.28.5.513.

28. Nie W, Xu P, Hao C, Chen Y, Yin Y, Wang L. Efficacy and safety of over-thecounter analgesics for primary dysmenorrhea: A network meta-analysis. Medicine. 2020;99(19):e19881. https://doi.org/10.1097/MD.0000000000019881.

29. Le Parc JM, Van Ganse E, Moore N, Wall R, Schneid H, Verrière F. Comparative tolerability of paracetamol, aspirin and ibuprofen for shortterm analgesia in patients with musculoskeletal conditions: results in 4291 patients. Clin Rheumatol. 2002;21(1):28–31. https://doi.org/10.1007/s100670200007.

30. Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen Safety at the Golden Anniversary: Are all NSAIDs the Same? A Narrative Review. Adv Ther. 2020;37(1):61–82. https://doi.org/10.1007/s12325-019-01144-9.

31. Zatsepina YY. Comparative analysis of the anti-inflammatory activity of some nonsteroidal anti-inflammatory drugs. International Research Journal. 2022;(9):1–4. (In Russ.) https://doi.org/10.23670/IRJ.2022.123.49.

32. Pursell E. Treating fever in children: paracetamol or ibuprofen? Br J Community Nurs. 2002;(7):316–320. https://doi.org/10.12968/bjcn.2002.7.6.10477.

33. Hay AD, Costelloe C, Redmond NM, Montgomery AA, Fletcher M, Hollinghurst S, Peters TJ. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ. 2008;337:a1302. https://doi.org/10.1136/bmj.a1302.

34. Morozova TE, AndruShchishina TB, Antipova EK. Ibuprofen: safety and efficiency of its use in wide clinical practice. Terapevticheskii Arkhiv. 2013;85(3):118–124. (In Russ.) Available at: https://ter-arkhiv.ru/0040-3660/article/view/31269.

35. Chiappini E, Principi N, Longhi R, Tovo PA, Becherucci P, Bonsignori F et al. Management of fever in children: summary of the Italian Pediatric Society guidelines. Clin Ther. 2009;31(8):1826–1843. https://doi.org/10.1016/j.clinthera.2009.08.006.

36. Pierce CA., Voss B. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review. Ann Pharmacother. 2010;44(3):489–506. https://doi.org/10.1345/aph.1m332.

37. Allan GM, Ivers N., Shevchuk Y. Treatment of pediatric fever: Are acetaminophen and ibuprofen equivalent? Can Fam Physician. 2010;56(8):773. Available at: https://pubmed.ncbi.nlm.nih.gov/20705883.

38. Autret-Leca E, Gibb IA, Goulder MA. Ibuprofen versus paracetamol in pediatric fever: objective and subjective findings from a randomized, blinded study. Curr Med Res Opin. 2007;23(9):2205–2211. https://doi.org/10.1185/030079907X223323.

39. Mennick F. Ibuprofen or acetaminophen in children? As the debate continues, the evidence may favor ibuprofen. Am J Nurs. 2004;104(9):20. Available at: https://pubmed.ncbi.nlm.nih.gov/15365323.

40. Wu CL, Raja SN. Treatment of acute postoperative pain. Lancet. 2011;377(9784):2215–2225. https://doi.org/10.1016/S0140-6736(11)60245-6.

41. No authors listed. Paracetamol or ibuprofen for fever or pain in children under 2 years old. J Paediatr Child Health. 2021;57(8):1342. https://doi.org/10.1111/jpc.15486.

42. Dronov IA, Geppe NA, Kolosova NG. Antipyretic therapy in children with acute respiratory infections: monotherapy or drug combination? Clinical Practice in Pediatrics. 2020;15(2):55–62. (In Russ.) https://doi.org/10.20953/18177646-2020-2-55-62.

43. Pikuza OI, Zakirova AM. Efficacy of combined antipyretics in therapy of acute respiratory conditions. Paediatrician Practice. 2016;(5):44–48. (In Russ.) Available at: https://medi.ru/info/12909.

44. Park YR, Kim H, Park JA, Ahn SH, Chang S, Shin JW et al. Comparative analysis of single and combined antipyretics using patient-generated health data: retrospective observational study. JMIR Mhealth Uhealth. 2021;9(5):e21668. https://doi.org/10.2196/21668.

45. Vyas FI, Rana DA, Patel PM, Patel VJ, Bhavsar RH. Randomized comparative trial of efficacy of paracetamol-ibuprofen combination for treatment of febrile children. Perspect Clin Res. 2014;5(1):25–31. https://doi.org/10.4103/2229-3485.124567.

46. Paul IM, Walson PD. Acetaminophen and ibuprofen in the treatment of pediatric fever: a narrative review. Curr Med Res Opin. 2021;37(8):1363–1375. https://doi.org/10.1080/03007995.2021.1928617.

47. Su J, Leyva R, Kellstein D, Cruz-Rivera M, Meeves S. Safety and tolerability of fixeddose combinations of ibuprofen and acetaminophen: pooled analysis of phase 1–3 clinical trials. Postgrad Med. 2021;133(5):565–571. https://doi.org/10.1080/00325481.2021.1912466.

48. Rainsford KD, Roberts SC, Brown S. Ibuprofen and paracetamol: relative safety in non-prescription dosages. J Pharm Pharmacol. 1997;49:345–376. https://doi.org/10.1111/j.2042-7158.1997.tb06809.x.

49. Preuss CV, Kalava A, King KC. Prescription of Controlled Substances: Benefits and Risks. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Available at: https://pubmed.ncbi.nlm.nih.gov/30726003.

50. Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children’s pain or fever: a meta-analysis. Arch Pediatr Adolesc Med. 2004;158(6):521–526. https://doi.org/10.1001/archpedi.158.6.521.

51. Carleton BC, Smith MA, Gelin MN, Heathcote SC. Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol. 2007;14(1):45–57. Available at: https://pubmed.ncbi.nlm.nih.gov/17297195.

52. Yewale VN, Dharmapalan D. Promoting appropriate use of drugs in children. Int J Pediatr. 2012;2012:906570. https://doi.org/10.1155/2012/906570.

53. de Martino M, Chiarugi A, Boner A, Montini G, De’ Angelis GL. Working Towards an Appropriate Use of Ibuprofen in Children: An Evidence-Based Appraisal. Drugs. 2017;77(12):1295–1311. https://doi.org/10.1007/s40265-017-0751-z.

54. Rainsford KD, Bjarnason I. NSAIDs: take with food or after fasting? J Pharm Pharmacol. 2012;64(4):465–469. https://doi.org/10.1111/j.2042-7158.2011.01406.x.

55. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA. 1995;273:929–933. Available at: https://pubmed.ncbi.nlm.nih.gov/7884951.

56. Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics. 1999;104:E39. https://doi.org/10.1542/peds.104.4.e39.

57. Morozova TE, Rykova SM, Yudina IYu. Ibuprofen in children: efficacy and safety profile. Paediatrician Practice. 2014;(4):18–22. Available at: https://medi.ru/info/5696.

58. Yerofeevа SB. Non-steroidal Anti-inflammatory Drugs In Pediatric Patients: Review Of The Efficacy And Safety. Farmateka. 2012;(Suppl. 2):48–52. (In Russ.) Available at: https://pharmateca.ru/ru/archive/article/8555?ysclid=m1p4hehbgf139096934.

59. Wallace LS, Keenum AJ, Devoe JE, Bolon SK, Hansen JS. Women’s Understanding of Different Dosing Instructions for a Liquid Pediatric Medication. J Pediatr Health Care. 2012;26(6):443–450. https://doi.org/10.1016/j.pedhc.2011.06.006.

60. Zakharova IN, Berezhnaya IV, Pupykina VV, Gostyukhina AD, Dubovets NF. Paracetamol and ibuprofen in the treatment of pain and fever in children: modern views on the choice of a drug. Meditsinskiy Sovet. 2023;17(17):84–90. (In Russ.) https://doi.org/10.21518/ms2023-367.

61. Gaul C, Eschalier A. Dose can help to achieve effective pain relief for acute mild to moderate pain with over-the-counter paracetamol. Open Pain J. 2018;11(1):12–20. https://doi.org/10.2174/1876386301811010012

62. Huijer HA-S Afshan, G, Albertyn HJ, Bell RF, Bertolino MS, Collins JJ et al. Рекомендации ВОЗ по медикаментозному лечению персистирующей боли у детей с соматическими заболеваниями. М.: Практическая медицина; 2014. 208 с. Режим доступа: https://fnkc.ru/ppp/rec-voz.pdf?ysclid=m1p4s0162i824283501.

63. Kato H, Fujigaki Y, Inoue R, Asakawa S, Shin S, Shima T et al. Therapeutic Dose of Acetaminophen as a Possible Risk Factor for Acute Kidney Injury: Learning from Two Healthy Young Adult Cases. Intern Med. 2014;53:1531–1534. https://doi.org/10.2169/internalmedicine.53.1502.

64. Karpov OI, Zaitsev AA. Safe pain treatment in outpatient settings: choice of drug. Lechaschi Vrach. 2003;(10). (In Russ.) Available at: https://www.lvrach.ru/2003/10/4530860.

65. Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17(6):275–342. https://doi.org/10.1007/s10787-009-0016-x.

66. Ngo VTH, Bajaj T. Ibuprofen. In: StatPearls. Treasure Island (FL): Stat Pearls Publishing; 2023. Available at: https://pubmed.ncbi.nlm.nih.gov/31194439.

67. Geppe NA. First International Conference on the Use of Ibuprofen in Pediatrics. RMJ. 2002;(18):831–835. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/K_40-letiyu_sozdaniya_ibuprofenaPervaya_meghdunarodnaya_konferenciya_po_primeneniyu_ibuprofena_v_pediatrii.

68. Sullivan JE, Farrar HC. Fever and antipyretic use in children. Pediatrics. 2011;127(3):580–587. https://doi.org/10.1542/peds.2010-3852.

69. Meremikwu M, Oyo-Ita A. Paracetamol for treating fever in children. Cochrane Database Syst Rev. 2002;(2):CD003676. https://doi.org/10.1002/14651858.cd003676.

70. Mofenson HC, McFee R, Caraccio T, Greensher J. Combined antipyretic therapy: another potential source of chronic acetaminophen toxicity. J Pediatr. 1998;133(5):712–714. https://doi.org/10.1016/s0022-3476(98)70121-0.

71. Purssell E. Combining paracetamol and ibuprofen for fever in children. BMJ. 2008;337:593. https://doi.org/10.1136/bmj.a1590.

72. Ushkalova EA. Safety profile of analgesics-antipyretics in pediatrics. RMJ. 2014;(21):1526. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Profily_bezopasnosti_analygetikov-antipiretikov_v_pediatrii.

73. Larrey D, Pageaux GP. Genetic predisposition to drug-induced hepatotoxicity. J Hepatol. 1997;26(2):12–21. https://doi.org/10.1016/s0168-8278(97)80492-8.

74. Sauerwein RW, Mulder JA, Mulder L, Lowe B, Peshu N, Demacker PN et al. Inflammatory mediators in children with protein-energy malnutrition. Am J Clin Nutr. 1997;65:1534–1539. https://doi.org/10.1093/ajcn/65.5.1534.

75. Zhang W, Parentau H, Greenly RL, Metz CA, Aggarwal S, Wainer IW, Tracy TS. Effect of protein-calorie malnutrition on cytochromes P450 and glutathione S-transferase. Eur J Drug Metab Pharmacokinet. 1999;24(2):141–147. https://doi.org/10.1007/BF03190359.

76. O’Shea D, Davis SN, Kim RB, Wilkinson GR. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clin Pharmacol Ther. 1994;56(4):359–367. https://doi.org/10.1038/clpt.1994.150.

77. Song BJ, Veech RL, Saenger P. Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. J Clin Endocrinol Metab. 1990;71(4):1036–1040. https://doi.org/10.1210/jcem-71-4-1036.

78. Shaoul R, Novikov J, Maor I, Jaffe M. Silent acetaminophen-induced hepatotoxicity in febrile children: does this entity exist? Acta Paediatr. 2004;93(5):618–622. https://doi.org/10.1111/j.1651-2227.2004.tb18256.x.

79. Purssell E. Systematic review of studies comparing combined treatment with paracetamol and ibuprofen, with either drug alone. Arch Dis Child. 2011;96(12):1175–1179. https://doi.org/10.1136/archdischild-2011-300424.

80. Baranova LN, Kupryashina NV, Lvova LV, Mazurenko DV, Morozenko OA, Muratkhuzina AR et al. Efficacy and safety of the fixed combination of ibuprofen paracetamol in febrile and pain syndromes in outpatient practice. Farmateka. 2012;(5):69–76. (In Russ.) Available at: https://pharmateca.ru/ru/archive/article/8396.

81. Геппе НА (ред.). Острые инфекции дыхательных путей у детей. Диагностика, лечение, профилактика: клиническое руководство. М.: МедКом-Про; 2020. 254 с. Режим доступа: http://ph.medcompro.ru/wp-content/uploads/2021/05/OIDP-verstka-05.11-1-15-1.pdf.

82. Pierce CA, Voss B. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a and qualitative review. Ann Pharmacother. 2010;44(3):489–450. https://doi.org/10.1345/aph.1M332.

83. Eustace N, O’Hare B. Use of nonsteroidal anti-inflammatory drugs in infants. A survey of members of the Association of Paediatric Anaesthetists of Great Britain and Ireland. Paediatr Anaesth. 2007;7(5):464–469. https://doi.org/10.1111/j.1460-9592.2007.02135.x.

84. Yilmaz HL, Alparslan N, Yildizdas D, Bayram I, Alhan E. Intramuscular Dipyrone versus Oral Ibuprofen or Nimesulide for Reduction of Fever in the Outpatient Setting. Clin Drug Investig. 2003;23(8):519–526. https://doi.org/10.2165/00044011-200323080-00004.

85. Pelen F. Treatment of Fever: monotherapy with ibuprofen. Ibuprofen pediatric suspension containing 100 mg/5 ml, Multicentre acceptability study conducted in hospital. Ann Pediatr. 1998;45(10):719–728.

86. Narayan K, Cooper S, Morphet J, Innes K. Effectiveness of paracetamol versus ibuprofen administration in febrile children: A systematic literature review. J Paediatr Child Health. 2017;53(8):800–807. https://doi.org/10.1111/jpc.13507.

87. St. Charles CS, Matt BH, Hamilton MM, Katz BP. A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy patient. Otolaryngol Head Neck Surg. 1997;117:76–82. https://doi.org/10.1016/s0194-59989770211-0.

88. Holloway AM, Logan DA. Comparison of oral ibuprofen with oral paracetamol for pain relief following tonsillectomy in children. Anaesth Intens Care. 1992;20:99–114.

89. Derkay CS, Wadsworth JT, Darrow DH, Strasnick B, Thompson GK, O’Master J. Tube placement: a prospective, randomized double-blind study. Laryngoscope. 1998;108(Pt. 1):97–101. https://doi.org/10.1097/00005537-199801000-00018.

90. Harley EH, Dattolo RA. Ibuprofen for tonsillectomy pain in children: efficacy and complications. Otolaryngol Head Neck Surg. 1998;119(5):492–496. https://doi.org/10.1016/s0194-5998(98)70107-x.

91. Baygin O, Tuzuner T, Isik B, Kusgoz A, Tanriver M. Comparison of pre-emptive ibuprofen, paracetamol, and placebo administration in reducing post-operative pain in primary tooth extraction. Int J Paediatr Dent. 2011;21(4):306–313. https://doi.org/10.1111/j.1365-263X.2011.01124.x.

92. Gazal G, Mackie IC. A comparison of paracetamol, ibuprofen or their combination for pain relief following extractions in children under general anaesthesia: a randomized controlled trial. Int J Paediatr Dent. 2007;17(3):169–177. https://doi.org/10.1111/j.1365-263X.2006.00806.x.

93. Agarkov NM, Fabrikantov OL, Lev IV, Nikolashin SI, Aksyonov VV. Features of the complement system in primary open-angle glaucoma and dry eye syndrome in the elderly. Medical Immunology. 2022;24(2):301–308 (In Russ.) https://doi.org/10.15789/1563-0625-fot-2394.

94. Agarkov NM, Makkonen KF, Aksenov VV, Tkachenko PV, Ivanov VA, Ivanov A., Subbotina TI. The differentiated diagnostic of chronic salpingoophoritis and ovary cancer on the basis of immunologic and discriminant techniquea. Klinichescheskaya Laboratornaya Diagnostika. 2017;62(10):611–615. (In Russ.) https://doi.org/10.18821/0869-2084-2017-62-10-611-615.

95. Diez-Domingo J, Planelles MV, Baldo JM, Ballester A, Núñez F, Jubert A, Domínguez-Granados R. Ibuprofen prophylaxis for adverse reactions to diphtheria-tetanus-pertussis vaccination: a randomized trial. Curr Ther Res. 1998;59(5):579–588. https://doi.org/10.1016/S0011-393X(98)85098-4.

96. Lava SA, Simonetti GD, Ramelli GP, Tschumi S, Bianchetti MG. Symptomatic management of fever by Swiss board-certified pediatricians: results from a cross-sectional, Web-based survey. Clin Ther. 2012;34(1):250–256. https://doi.org/10.1016/j.clinthera.2011.12.002.

97. Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 1972;240(5381):410–411. https://doi.org/10.1038/240410a0.

98. Mallet C, Desmeules J, Pegahi R, Eschalier A. An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact. J Pain Res. 2023;16:1081–1094. https://doi.org/10.2147/jpr.s393809.

99. Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201–232. https://doi.org/10.1007/s10787-013-0172-x.

100. Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006;12(3-4):250–275. https://doi.org/10.1111/j.1527-3458.2006.00250.x.

101. Тимченко ВН, Павлова ЕБ. Опыт применения препарата «Нурофен для детей» в лечении инфекционных заболеваний у детей. СПб.; 2006.

102. Klyuchnikov SO, Barsukova MV, Dubovich EG, Suyundukova AS. Rational approaches to the use of antipyretic drugs in children. RMJ. 2010;(5):243–247. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Racionalynye_podhody_k_primeneniyugharoponighayuschih_preparatov_u_detey.

103. Autret E, Reboul-Marty J, Henry-Launois B, Laborde C, Courcier S, Goehrs JM et al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. Eur J Clin Pharmacol. 1997;51(5):367–371. https://doi.org/10.1007/s002280050215.

104. Agarkov NM, Gorko TS, Lev IV, Shchekaturov AA, Shabalin AA. Changes in the blood complement system in the development of diabetic retinopathy in the elderly. Research Results in Biomedicine. 2021;7(2):173–180. (In Russ.) https://doi.org/10.18413/2658-6533-2021-7-2-0-8.

105. ESCMID Sore Throat Guideline Group; Pelucchi C, Grigoryan L, Galeone C, Esposito S, Huovinen P, Little P, Verheij T. Guideline for the management of acute sore throat. Clin Microbiol Infect. 2012;18(Suppl. 1):1–28. https://doi.org/10.1111/j.1469-0691.2012.03766.x.

106. Dwarica DS, Pickett SD, Zhao YD, Nihira MA, Quiroz LH. Comparing Ketorolac With Ibuprofen for Postoperative Pain: A Randomized Clinical Trial. Female Pelvic Med Reconstr Surg. 2020;26(4):233–238. https://doi.org/10.1097/spv.0000000000000740.

107. Timmerman A, Parashos P. Management of dental pain in primary care. Aust Prescr. 2020;43(2):39–44. https://doi.org/10.18773/austprescr.2020.010.

108. Баранов АА, Намазова-Баранова ЛС, Лобзин ЮВ, Таточенко ВК, Усков АН, Куличенко ТВ и др. Острая респираторная вирусная инфекция (ОРВИ): клинические рекомендации. 2021. 41 с. Режим доступа: https://www.pediatr-russia.ru/information/klin-rek/proekty-klinicheskikhrekomendatsiy/ОРВИ%20дети%20СПР_1.06.2021.pdf.

109. Anderson B. Paracetamol. In: Jacqz-Aigrain E, Choonara I (eds.). Paediatric Clinical Pharmacology. New York: Taylor & Francis; 2006, pp. 621–627.

110. Magni AM, Scheffer DK, Bruniera P. Antipyretic effect of ibuprofen and dipyrone in febrile children. J Pediatr (Rio J). 2011;87(1):36–42. https://doi.org/10.2223/JPED.2060.

111. Rozhdestvensky DA. Clinical pharmacology of analgesics-antipyretics: features of modern dosage forms of ibuprofen. Lechebnoe Delo. 2015;(5):17–20. (In Russ.) Available at: https://www.elibrary.ru/vctrff.